Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harmony Biosciences Holdings (HRMY) Assets: 2019-2025

Historic Assets for Harmony Biosciences Holdings (HRMY) over the last 5 years, with Sep 2025 value amounting to $1.2 billion.

  • Harmony Biosciences Holdings' Assets rose 30.18% to $1.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 billion, marking a year-over-year increase of 30.18%. This contributed to the annual value of $999.2 million for FY2024, which is 23.14% up from last year.
  • As of Q3 2025, Harmony Biosciences Holdings' Assets stood at $1.2 billion, which was up 9.04% from $1.1 billion recorded in Q2 2025.
  • In the past 5 years, Harmony Biosciences Holdings' Assets registered a high of $1.2 billion during Q3 2025, and its lowest value of $337.3 million during Q1 2021.
  • Over the past 3 years, Harmony Biosciences Holdings' median Assets value was $858.4 million (recorded in 2024), while the average stood at $915.4 million.
  • Data for Harmony Biosciences Holdings' Assets shows a peak YoY spiked of 64.53% (in 2022) over the last 5 years.
  • Over the past 5 years, Harmony Biosciences Holdings' Assets (Quarterly) stood at $433.4 million in 2021, then skyrocketed by 55.47% to $673.9 million in 2022, then rose by 20.42% to $811.4 million in 2023, then rose by 23.14% to $999.2 million in 2024, then spiked by 30.18% to $1.2 billion in 2025.
  • Its last three reported values are $1.2 billion in Q3 2025, $1.1 billion for Q2 2025, and $1.1 billion during Q1 2025.